Member Info for Compoundinterest

Wyn, thanks for sharing your detailed opinions! Good read as always. I agree, the price action both indicate shareholder exit and a possible rights issue coming. It's not possible to deliver on a 700m+ contract without significant funding to back the project. So the selling after such wonderful news suggest to me that an II wants out and may not want to fully participate in RI if any. I think a good time would be after the rights issue if it does happen IMO. What do u mean by FA POV?

As for your comments AGL.. I agree completely. Wait and see.

I added some ONC today. RSI still at 50 though.. not sure if it will fall further or support will hold and hopefully upwards to 70s+. IMO, DYOR.

Any new thoughts on Angle? drifted back down to 28p, RSI now 38.. heading towards the nearly oversold territory.

My guess HARL is down today cos Killik & Co LLP still selling their holdings, seems they are keen to exit from their pattern shown in the RNS IMO, DYOR. I would caution buying too much until there is a clearer indication of them halting sells. IMO, DYOR.

Thanks for your post on ONC. Also comments on HARL. I am quite curious on ur thoughts for HARL, on what looks to be excellent news on the finalisation of 700m contract, why is it down? "Sell on the news". Cheers

Hi Wyn, what ur thoughts on the price action from a TA perspective now? I remember u mentioned, u may consider adding if falls to 63ish. What's your opinion now? Seems there is not much support right now. Thanks

Hi guys, what are your thoughts on Angle Plc? RSI around 30 now... dropped back down to 27p. Is it oversold and are we touching bottom or more to go? Or wait and see and buy on a clearer indication of reversal?

The 1 week RSI is now 58 since the share price drops to 68p when RSI was 80 at 73p. Seems your prediction of short term pullback to 60s is quite accurate prediction. The RSI is quite a fascinating indicator...

I think to answer your question whether to sell and buy lower down or trend strong enough so hold, my answer is hold most and sell partially. I do believe it is only a short-term pullback and I do think it will only be a few days before rising back, and since the spreads are quite high, I am not sure how much margin I can make buy short-term sell and then buy back in so I figured it's not worth the risk to sell now during a strong trend up. I will start to sell when the peak of trend stablises IMO, DYOR.

Thanks for sharing your thoughts Wyn. Seems RSI reached 80 which according to ur previous comments is overbought territory. Do u think it is temporary before we head higher in which case would RSI continue to be high or go lower first. if according to ur analysis it is currently a bit toppy and we head to low to mid 60s, what's your timeline expectation before we head towards 80s? It seems timing is everything. GL!

Nice prediction Wyn. It did move very quickly! How did u determine support level at 58p? and what do u think 76.5p is next target giving it a 4-1risk/reward. Fascinating... what u think will happen next? Will u buy more since the small bite last time. GL!

We are starting to see some momentum now with buys. Looking exciting over the next few days, weeks and months. Now that Biodesix (US distributor) has US Medicare and insurance payers covered, hoping this will increase sales royalties for Oncimmunes Early CDT earnings. GLA

Good luck Geeman! fingers crossed for u.

Another note, I don't know much about AVCT, but some general advise as the saying goes not to not put all your eggs in one basket.And If you had a fresh piece of paper, how would you allocate your portfolio? Quite easy to emotionally attached to one stock. Eve Sleep costs me a lot more than it should have... hoping it doesn't happen to others too. GL

Geeman Happy NY. Wishing this year would be a prosperous one for u. I've also been following AGL for some time. Bought when they got FDA clearance and then sold at a loss soon after when I realised it lost momentum. That was when it was 150p... now it's crazy 27p.. but market cap it around 70mil with 30mil cash in bank so could go down more. No idea where the bottom is... Any thoughts? I am done catching bottoms like I did with Eve sleep.. adjusting my strategy to trying to buy on the way up. Lets see how that works. ONC is also in liquid biopsies too.. except their US distributor is starting to show some legs and a bit of results.

Great to have u on board Wyn. Good you have a bit of skin in the game. Look forward to ur future analysis and opinions :)

Thanks for your valuable TA and opinions as always!

Yes certainly very interesting company, the FA is very attractive especially their exclusive US distributor Biodesix has just raised $90m to further support the commercialisation efforts of their main product from Oncimmune. Their liquid biopsy for diagnosing lung cancer has medicare coverage and yesterday announced the signings with 4 private payer insurance coverage too. Hopefully results in higher sales and royalty payments to ONC.

Hi guys, would be great to learn your opinions on the following company Oncimmune (ONC), also similar to Angle a liquid biopsy company but ONC also provides big pharma with CRO related biomarker services. Would be good to learn ur comments. Also from Wyn from a TA perspective. Thanks.

Onwards and upwards

More good news, Oncimmune's US distributor signs 4 new four private payers insurance coverage of approximately 4.5 million people.

Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test - link below
https://investors.biodesix.com/news-releases/news-release-details/biodesix-announces-first-four-private-payer-coverage-policies

Certain directors intending to subscribe for £1.2mln- I am guessing a large proportion of that is from the new Chairman Alistair. I guessing the new appointed non-exe director John Goold who just started a new fund listed on LSE will also invest. This looks like insiders taking a position before the company reaches inflexion point next year with EarlyCDT Lung expected to grow significantly over the short-term as Biodesix their US distributor raises $90mil to fund expansion. I have high hopes for this one 12 months from now. GLA, DYOR, IMO.

Good question Gamblors, I did not find the royalty numbers. But it does say Biodesix will pay Oncimmune a total of $28 million over five years. I am guessing this is equivalent to the licensing rights for EarlyCDT excluding COGS and Royalty.

https://www.fiercebiotech.com/medtech/biodesix-acquires-oncimmune-s-u-s-lab-for-rule-lung-nodule-cancer-blood-test